J.B.CHEMICALS | BH.IMMUN&BIO | J.B.CHEMICALS/ BH.IMMUN&BIO |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 54.2 | -7.5 | - | View Chart |
P/BV | x | 11.8 | 1.5 | 809.5% | View Chart |
Dividend Yield | % | 0.5 | 0.0 | - |
J.B.CHEMICALS BH.IMMUN&BIO |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
J.B.CHEMICALS Mar-23 |
BH.IMMUN&BIO Mar-23 |
J.B.CHEMICALS/ BH.IMMUN&BIO |
5-Yr Chart Click to enlarge
|
||
High | Rs | 2,150 | 52 | 4,150.4% | |
Low | Rs | 1,339 | 21 | 6,532.0% | |
Sales per share (Unadj.) | Rs | 407.0 | 10.3 | 3,939.5% | |
Earnings per share (Unadj.) | Rs | 53.0 | -3.9 | -1,375.0% | |
Cash flow per share (Unadj.) | Rs | 67.8 | -3.8 | -1,780.1% | |
Dividends per share (Unadj.) | Rs | 8.88 | 0 | - | |
Avg Dividend yield | % | 0.5 | 0 | - | |
Book value per share (Unadj.) | Rs | 304.8 | 20.4 | 1,492.1% | |
Shares outstanding (eoy) | m | 77.38 | 43.18 | 179.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 3.5 | 122.5% | |
Avg P/E ratio | x | 32.9 | -9.4 | -350.9% | |
P/CF ratio (eoy) | x | 25.7 | -9.5 | -271.1% | |
Price / Book Value ratio | x | 5.7 | 1.8 | 323.4% | |
Dividend payout | % | 16.7 | 0 | - | |
Avg Mkt Cap | Rs m | 134,983 | 1,561 | 8,647.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 5,435 | 151 | 3,588.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 31,493 | 446 | 7,059.7% | |
Other income | Rs m | 99 | 11 | 937.7% | |
Total revenues | Rs m | 31,592 | 457 | 6,917.7% | |
Gross profit | Rs m | 6,958 | -161 | -4,329.8% | |
Depreciation | Rs m | 1,144 | 2 | 57,203.5% | |
Interest | Rs m | 361 | 71 | 510.7% | |
Profit before tax | Rs m | 5,552 | -223 | -2,493.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1,452 | -56 | -2,580.0% | |
Profit after tax | Rs m | 4,100 | -166 | -2,464.1% | |
Gross profit margin | % | 22.1 | -36.0 | -61.3% | |
Effective tax rate | % | 26.2 | 25.3 | 103.5% | |
Net profit margin | % | 13.0 | -37.3 | -34.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 15,993 | 358 | 4,466.9% | |
Current liabilities | Rs m | 6,257 | 940 | 665.3% | |
Net working cap to sales | % | 30.9 | -130.6 | -23.7% | |
Current ratio | x | 2.6 | 0.4 | 671.4% | |
Inventory Days | Days | 85 | 85 | 99.7% | |
Debtors Days | Days | 667 | 1,135 | 58.8% | |
Net fixed assets | Rs m | 24,988 | 1,262 | 1,980.2% | |
Share capital | Rs m | 155 | 432 | 35.8% | |
"Free" reserves | Rs m | 23,433 | 450 | 5,203.3% | |
Net worth | Rs m | 23,587 | 882 | 2,673.9% | |
Long term debt | Rs m | 3,832 | 0 | - | |
Total assets | Rs m | 40,981 | 1,620 | 2,529.8% | |
Interest coverage | x | 16.4 | -2.2 | -761.4% | |
Debt to equity ratio | x | 0.2 | 0 | - | |
Sales to assets ratio | x | 0.8 | 0.3 | 279.1% | |
Return on assets | % | 10.9 | -5.9 | -184.1% | |
Return on equity | % | 17.4 | -18.9 | -92.2% | |
Return on capital | % | 21.6 | -17.2 | -125.1% | |
Exports to sales | % | 40.6 | 0 | - | |
Imports to sales | % | 17.5 | 14.5 | 120.8% | |
Exports (fob) | Rs m | 12,784 | NA | - | |
Imports (cif) | Rs m | 5,500 | 65 | 8,524.3% | |
Fx inflow | Rs m | 12,784 | 0 | - | |
Fx outflow | Rs m | 5,500 | 65 | 8,524.3% | |
Net fx | Rs m | 7,284 | -65 | -11,289.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 6,256 | 109 | 5,743.8% | |
From Investments | Rs m | -9,618 | 5 | -208,179.2% | |
From Financial Activity | Rs m | 3,565 | -147 | -2,423.5% | |
Net Cashflow | Rs m | 204 | -34 | -607.4% |
Indian Promoters | % | 0.0 | 59.3 | - | |
Foreign collaborators | % | 53.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 28.9 | 0.0 | - | |
FIIs | % | 10.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 46.2 | 40.8 | 113.3% | |
Shareholders | 63,230 | 34,910 | 181.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare J.B.CHEMICALS With: CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | J.B.Chemicals | BH.IMMUN&BIO | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.13% | -1.68% | 0.35% |
1-Month | 11.55% | 6.20% | 2.33% |
1-Year | 67.69% | 16.45% | 54.34% |
3-Year CAGR | 43.44% | -8.49% | 15.02% |
5-Year CAGR | 58.96% | 27.55% | 19.24% |
* Compound Annual Growth Rate
Here are more details on the J.B.Chemicals share price and the BH.IMMUN&BIO share price.
Moving on to shareholding structures...
The promoters of J.B.Chemicals hold a 53.8% stake in the company. In case of BH.IMMUN&BIO the stake stands at 59.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of J.B.Chemicals and the shareholding pattern of BH.IMMUN&BIO.
Finally, a word on dividends...
In the most recent financial year, J.B.Chemicals paid a dividend of Rs 8.9 per share. This amounted to a Dividend Payout ratio of 16.7%.
BH.IMMUN&BIO paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of J.B.Chemicals, and the dividend history of BH.IMMUN&BIO.
For a sector overview, read our pharmaceuticals sector report.
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.